Conference Description

September 16, 2006
Crowne Plaza Hotel Atlanta-Ravinia
4355 Ashford Dunwoody
Atlanta, Georgia 30346
877-227-6963

Tell a friend about this conference

Download the brochure for this conference

See how attendees evaluated this conference

CME Credits: 7.5*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:
This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. more fully understand the origins of insulin resistance and type 2 Diabetes, and review studies of atherosclerosis prevention in patients with type 2 Diabetes
2. utilize appropriate first line therapies in the treatment of diabetes with the goal of targeting the various metabolic pathways in the management of hyperglycemia, thereby preventing development of complications
3. understand the role for insulin in patients with type 2 diabetes and develop strategies for initiating and adjusting therapy
4. discuss the epidemiology, diagnostic evaluation, and treatment options of thyroid nodules
5. evaluate and diagnose the anemia of chronic kidney disease, understand its impact on quality of life, and guide treatment decisions based on emerging data
6. understand that COPD is not only a problem of the lungs but also a disease with important systemic consequences that does respond to many forms of effective therapy
7. recognize the signs of Pulmonary Arterial Hypertension, guide appropriate evaluation and discuss the latest therapeutic options
8. utilize evolving data and novel therapies to understand and more effectively manage patients with chronic constipation
9. recognize the importance of achieving the recommended goal blood pressure rather than the superiority of a specific antihypertensive over another in improving patient outcome and understanding the importance of combination therapy to achieve effective blood pressure control

Agenda:

7:30-8:00 am		Registration, Continental Breakfast and Welcome
8:00-8:10		Welcome Remarks Gregg Sherman, MD
8:10-9:00		Insulin Resistance: From Impaired Glucose Tolerance to Type 2 Diabetes – Pathophysiologic Origins, Progression to Diabetes, Prevention of Atherosclerosis Patrick Boyle, MD
9:00-9:50		Treatment Early in the Time Course of Type 2 Diabetes Patrick Boyle, MD
9:50-10:10		Break
10:10-11:00		Beyond Oral Agents: Insulin Initiation and Management Cristina Mata MD
11:00-11:50		Difficult Constipation: Getting to the Bottom of It Amy Foxx-Orenstein, DO, FACG, FACP
11:50-12:40		Thyroid Nodule Evaluation 2006 John B. Tourtelot, MD, FACE, FACP
12:40-1:30		Lunch
1:30-2:20		COPD: An Optimistic View Bart Celli, MD
2:20-3:10		Pulmonary Hypertension Wendy Book, MD
3:10-3:30		Break
3:30-4:20		Anemia in Chronic Kidney Disease: Clinical Implications and Treatment Options William McClellan, Jr., MD, MPH
4:20-5:10		The Importance of Blood Pressure Control in The Management of Hypertension: Improving Outcomes in 2006 Jan N. Basile, MD
5:10		Conference Wrap Up Gregg Sherman, MD

Faculty:
Jan N. Basile, MD
Professor of Medicine in the Division of General Internal
Medicine/Geriatrics at the Medical University of South Carolina
Director in Primary Care
at the Ralph H. Johnson VA Medical Center,
Charleston, South Carolina

Wendy Book, MD
The Emory Clinic
Assistant Professor of Medicine, Div. Of Cardiology
Co-Director Emory Adult Congenital Cardiac Program
Atlanta, GA

Patrick J. Boyle, MD
Professor of Medicine
University of New Mexico

Bart Celli, MD
Chief, Division of Pulmonary and Critical Care Medicine
Tufts University
Caritas St. Elizabeth’s Medical Center,
Boston, MA

Amy Foxx-Orenstein, DO, FACG, FACP
Vice-President, American College of Gastroenterology

Cristina Mata, MD
Medical Director of Diabetes Services
Holy Cross Hospital
Fort Lauderdale, FL

William McClellan, Jr., MD, MPH
Professor, Department of Medicine,
Division of Renal Medicine
Emory University School of Medicine

John B. Tourtelot, MD, FACE, FACP
Assistant Professor of Medicine,
Department of Family Practice,
University of South Florida

Program Chair: Gregg Sherman, MD

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 7.5 Prescribed credits by the American Academy of Family Physicians.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. UMMS is accredited by ACCME to provide continuing medical education for physicians. UMMS designates this continuing medical education activity for 7.5 credit hours in Category I toward the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 9.0 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spend in the educational activity.

This program was supported through educational grants from the following companies: Abbott Laboratories, Actelion, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Novo nordisk, Pfizer, sanofi-aventis, Takeda, Wyeth.